BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21054260)

  • 1. Could sigma receptor ligands be a treatment for methamphetamine addiction?
    Rodvelt KR; Miller DK
    Curr Drug Abuse Rev; 2010 Sep; 3(3):156-62. PubMed ID: 21054260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.
    Rodvelt KR; Oelrichs CE; Blount LR; Fan KH; Lever SZ; Lever JR; Miller DK
    Drug Alcohol Depend; 2011 Jul; 116(1-3):203-10. PubMed ID: 21277708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
    Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
    Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.
    Hedges DM; Obray JD; Yorgason JT; Jang EY; Weerasekara VK; Uys JD; Bellinger FP; Steffensen SC
    Neuropsychopharmacology; 2018 May; 43(6):1405-1414. PubMed ID: 29185481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.
    Sambo DO; Lebowitz JJ; Khoshbouei H
    Pharmacol Ther; 2018 Jun; 186():152-167. PubMed ID: 29360540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.
    Matsumoto RR; Nguyen L; Kaushal N; Robson MJ
    Adv Pharmacol; 2014; 69():323-86. PubMed ID: 24484982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
    Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
    Jing L; Li JX
    Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice.
    Tapia MA; Lever JR; Lever SZ; Will MJ; Park ES; Miller DK
    Psychopharmacology (Berl); 2019 Nov; 236(11):3147-3158. PubMed ID: 31139878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice.
    Miller DK; Park ES; Lever SZ; Lever JR
    Pharmacol Biochem Behav; 2016; 150-151():198-206. PubMed ID: 27851908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC; McCracken KA; Liu Y; Pouw B; Matsumoto RR
    Neuropharmacology; 2005 Oct; 49(5):638-45. PubMed ID: 15939443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
    Volz TJ; Fleckenstein AE; Hanson GR
    Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
    London ED
    Adv Pharmacol; 2016; 76():67-84. PubMed ID: 27288074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine and the expanding complications of amphetamines.
    Albertson TE; Derlet RW; Van Hoozen BE
    West J Med; 1999 Apr; 170(4):214-9. PubMed ID: 10344175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New synthesis of tic-hydantoins sigma-1 ligands and pharmacological evaluation on cocaine-induced stimulant effects.
    Toussaint M; Debreu-Fontaine MA; Maurice T; Melnyk P
    Med Chem; 2010 Nov; 6(6):355-73. PubMed ID: 20843289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
    Seminerio MJ; Robson MJ; Abdelazeem AH; Mesangeau C; Jamalapuram S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2012 Mar; 14(1):43-51. PubMed ID: 22183188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.